Editor's Choice - The Implications of Non-compliance to Endovascular Aneurysm Repair Surveillance: A Systematic Review and Meta-analysis. by Grima, MJ et al.
Eur J Vasc Endovasc Surg (2017) -, 1e11REVIEWThe Implications of Non-compliance to Endovascular Aneurysm Repair
Surveillance: A Systematic Review and Meta-analysis
Matthew Joe Grima a,b,*, Mourad Bouﬁ a,c,e, Martin Law d, Dan Jackson d, Kate Stenson a,b, Benjamin Patterson a,b, Ian Loftus a,b,
Matt Thompson a,b, Alan Karthikesalingam a,b, Peter Holt a,b
a St George’s Vascular Institute, St George’s Hospital, NHS Foundation Trust, London, UK
bMolecular and Clinical Sciences Research Institute, St George’s, University of London, London, UK
c Aix-Marseille Université, CNRS, IRPHE UMR 7342, Marseille, France
dMRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
e APHM, Department of Vascular Surgery, University Hospital Nord, Marseille, France* Co
Terrace
E-ma
Twitt
1078
NC-ND
https
Please
RevieWHAT THIS PAPER ADDS
Surveillance imaging is considered mandatory after endovascular aneurysm repair (EVAR), but many patients are
either non-compliant or lost to follow-up, and the impact of this is poorly understood. This review highlights and
conﬁrms the great variability in published EVAR surveillance compliance rates. This study also suggests that
although compliance may be associated with increased re-interventions after EVAR, surveillance does not
appear to confer a survival advantage to compliant patients in the ﬁrst 5 years after EVAR.Objective/background: Increasingly, reports show that compliance rates with endovascular aneurysm repair
(EVAR) surveillance are often suboptimal. The aim of this study was to determine the safety implications of non-
compliance with surveillance.
Methods: The study was carried out according to the Preferred Items for Reporting of Systematic Reviews and
Meta-Analyses (PRISMA) guidelines. An electronic search was undertaken by two independent authors using
Embase, MEDLINE, Cochrane, and Web of Science databases from 1990 to July 2017. Only studies that analysed
infrarenal EVAR and had a deﬁnition of non-compliance described as weeks or months without imaging
surveillance were analysed. Meta-analysis was carried out using the random-effects model and restricted
maximum likelihood estimation.
Results: Thirteen articles (40,730 patients) were eligible for systematic review; of these, seven studies (14,311
patients) were appropriate for comparative meta-analyses of mortality rates. Three studies (8316 patients) were
eligible for the comparative meta-analyses of re-intervention rates after EVAR and four studies (12,995 patients)
eligible for meta-analysis for abdominal aortic aneurysm related mortality (ARM). The estimated average non-
compliance rate was 42.0% (95% conﬁdence interval [CI] 28e56%). Although there is some evidence that non-
compliant patients have better survival rates, there was no statistically signiﬁcant difference in all cause mortality
rates (year 1: odds ratio [OR] 5.77, 95% CI 0.74e45.14; year 3: OR 2.28, 95% CI 0.92e5.66; year 5: OR 1.81, 95% CI
0.88e3.74) and ARM (OR 1.47, 95%CI 0.99e2.19) between compliant and non-compliant patients in the ﬁrst 5 years
after EVAR.The re-intervention rate was statistically signiﬁcantly higher in compliant patients from 3 to 5 years after
EVAR (year 1:OR6.36, 95%CI 0.23e172.73; year 3:OR3.94, 85%CI 1.46e10.69) year 5:OR5.34, 95%CI 1.87e15.29).
Conclusion: This systematic review and meta-analysis suggest that patients compliant with EVAR surveillance
programmes may have an increased re-intervention rate but do not appear to have better survival rates than
non-compliant patients.
 2017 The Author(s). Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Despite endovascular aneurysm repair (EVAR) being the
modern preferred ﬁrst choice for repair of abdominal aortic
aneurysms (AAA),1,2 studies show that re-interventions af-
ter EVAR are common and are undertaken in around 20% of
patients within 5 years.3,4 Consequently, guidelines from
learned societies recommend lifelong annual imaging in
order to identify and treat aortic complications to prevent
aneurysm rupture and death.5e7 However, published pop-
ulation and observational studies show that patients are
not always compliant with their surveillance programmes.8,9
A number of studies have attempted to evaluate patient
characteristics that may be associated with poor compliance
rates.8,10 Despite this, little is known about the conse-
quence of non-compliance with surveillance. Thus, a sys-
tematic review and meta-analysis was undertaken to study
the implications of non-compliance with EVAR surveillance
programmes. The primary outcomes were overall compli-
ance, all cause mortality (ACM), and re-intervention rates
and the secondary outcome was aneurysm related mortality
(ARM).METHODS
The studywas carried out according to the Preferred Items for
Reporting of Systematic Reviews and Meta-Analyses
(PRISMA) guidelines.11 An electronic search was undertaken
by two independent authors using the Embase, Medline, and
Cochrane databases from 1990 to July 2017. Studies that
assessed the compliance rate with surveillance after EVAR
and analysed the relationship of re-intervention andmortality
rates with compliance rates were identiﬁed.The search terms
(including medical subject sub-headings) “abdominal aortic
aneurysm”,“aneurysm”,“AAA”,“EVAR”,“endovascular repair”,
“compliance”, “surveillance”, “follow-up”, and “survey” were
used in combination with Boolean operators AND or OR. The
reference lists of articles obtained were investigated to
identify relevant citations. Conference abstracts from major
vascular meetings, when published online, were also scruti-
nised through the Web of Science database (full search his-
tory is available in the Supplementary Material).
Inclusion criteria encompassed all studies describing
endovascular repair of infrarenal AAA. The studies needed
to have a deﬁnition of non-compliance described as weeks
or months without imaging surveillance. Exclusion criteria
included non-English language papers, thoraco-abdominal
aortic aneurysm repair, suprarenal AAA, fenestrated grafts,
parallel grafts, iliac aneurysms, and patients treated with
the endovascular aneurysm sealing technique.
Studies that provided follow-up data using statistical
methods for survival analysis were used for comparative
meta-analyses of ACM and re-intervention rates. Quality
assessment was carried out independently by two authors
using Grading of Recommendations, Assessment, Develop-
ment and Evaluations (GRADE),12 and differences were
resolved through discussion between the two authors.
Outcome data were obtained from at risk scores provided
with the tables and graphs when available, but if not, dataPlease cite this article in press as: Grima MJ, et al., The Implications of Non-
Review and Meta-analysis, European Journal of Vascular and Endovascular Suwere extracted from KaplaneMeier curves. Attempts were
made to contact the authors whenever data required were
not readily available.
ARM was standardised by Chaikof et al. as deaths sec-
ondary to aneurysm rupture, EVAR to open conversion, and
the index or secondary procedure (see Table 7).13
As different institutions and studies used different deﬁ-
nitions for non-compliance, a laxity index was developed by
the authors at the outset of the study. The laxity index is a
measure of the stringency of the studies’ deﬁnition of non-
compliance. The laxity index was based on the number of
scans missed and the number of months without imaging. A
laxity value (from 0 to 1) was attributed to studies. A low
laxity index suggests a very rigid application of the sur-
veillance protocol, such that minimal deviation was labelled
as non-compliance (detailed explanation is available in the
Supplementary Material).Statistical analysis
Statistical analysis was carried out using ‘R package meta-
for’. Random effects meta-analyses were performed using
restricted maximum likelihood estimation.14 The meta-
analysis for the non-compliance rates was performed
using the observed rates and standard methods for a non-
comparative proportion. For four of the papers,8,15e17
reported longer-term compliance rates were used to
determine the necessary outcome data.
The comparative meta-analyses of ACM and re-
intervention rates were performed at ﬁve time points (1,
2, 3, 4, and 5 years) after intervention. The outcome data
were empirical log-odds ratios (ORs) that compare the all
cause mortality and re-intervention rates of the compliant
and non-compliant patients. In order to include outcome
data where KaplaneMeier curves indicated that the event
rate was negligible, the corresponding outcome data were
analysed using the rate where half a person had experi-
enced the event. Random effects meta-analyses were done
using standard methods, where a conservative sample size
was used for calculating the within study variances, so that
censoring resulted in the maximum possible loss of infor-
mation.18 This sample size calculation requires the number
at risk at each time point. Most papers gave these or values
at adjacent time points that could be used for interpolation.
Where numbers at risk were not given in study reports, for
the purposes of calculating within study variances, the
sample sizes were reduced by the average percentage
reduction across the other studies that contribute to the
analysis. Pooled estimates were transformed to the OR
scale, where an OR that is > 1 indicates that the mortality
or re-intervention rate is higher in compliant patients. To
account for confounding factors, matched cohorts were
used where possible. This included the studies by Garg et al.
and Hicks et al. for comparative meta-analyses of mortal-
ity,16,19 and the study by Garg et al. for comparative meta-
analyses of re-intervention rates.19
Five random effects meta-regression models were ﬁtted
where the overall survival log-ORs were regressed on thecompliance to Endovascular Aneurysm Repair Surveillance: A Systematic
rgery (2017), https://doi.org/10.1016/j.ejvs.2017.11.030
EVAR Surveillance: A Systematic Review and Meta-analysis 3laxity index. Here the regression coefﬁcient is a log-OR that
is associated with a change in the laxity index from its
minimum (0) to its maximum (1). A positive regression
coefﬁcient indicates that a greater laxity index is associated
with larger ORs. A single comparative meta-analysis of the
rates of ARM was performed. Here a random effects meta-
analysis was performed, using empirical log-ORs as outcome
data, and as in the other comparative meta-analyses.
For three studies,16,20,21 KaplaneMeier curves for “non-
compliant” groups and “lost to follow-up” were provided
separately. It was agreed that, although the “lost to follow-
up” group is a more non-compliant group, this particular
survival curve would not be analysed for meta-analysis. This
decision was taken as this provides a more conservative
analysis and avoids statistical issues involved in recon-
structing KaplaneMeier curves de novo (which would be a
combination of non-compliant and lost to follow-up). Thus,
the results produced will be more transparent and easily
reproducible.
Elective and emergency cases of AAA repair could not be
distinguished to statistically assess the impact of survival
and re-intervention rate. Thus, the statistical outcomes do
not refer to elective or rupture patients independently.
In the study by Hicks et al.,16 an assumption was agreed
by the authors, whereby patients who had telephone
follow-up were considered as non-compliant, whereas pa-
tients who attended clinic for follow-up were considered as
compliant. This was done in order to resemble the current
real world scenario where patients physically attend follow-
up sessions. Given that the recorded follow up in the
Vascular Quality Initiative register is only for 1 year after
EVAR, a sensitivity analysis for all cause mortality excluding
the study by Hicks et al. was carried out.16
RESULTS
After screening, the literature search identiﬁed 31 articles
that discussed compliance after EVAR. Of these 31 articles,
18 were excluded for various reasons (Fig. 1).9,10,22e37 Of
the 13 articles that were suitable for systematic review,8,15e
17,19e21,38e43 seven studies were eligible for comparative
meta-analysis of ACM.16,19e21,40e42 Three were eligible for
comparative meta-analyses of re-intervention rates after
EVAR,19,40,42 whereas four studies were eligible for random
effects meta-analyses of ARM.19,20,41,42 The study by God-
frey et al.,38 despite providing a survival analysis curve, was
not eligible for inclusion in meta-analysis owing to a
different deﬁnition of non-compliance as compared with
other papers. This was conﬁrmed when the corresponding
author was contacted.Primary outcomes
Compliance. Using the seven studies that contributed to
the comparative meta-analysis, the estimated average non-
compliance rate (according to the papers’ speciﬁc criteria
for determining this) was 42% (95% conﬁdence interval [CI]
28e56% [26,622 patients: 15,255 compliant; 11,367 non-
compliant]) (Fig. 2). This ﬁnding is consistent even if thePlease cite this article in press as: Grima MJ, et al., The Implications of Non-
Review and Meta-analysis, European Journal of Vascular and Endovascular Sunon-compliance rates of the other four studies were
included, where the non-compliance rate was 38% (95% CI
27e48%), (40,730 patients: 22,971 compliant; 17,759 non-
compliant) (Fig. 2, Table 1). Overall quality of evidence is
“moderate” (Table 2).12
ACM. In total, 14,311 patients (6947 compliant and 7364
non-compliant) contributed to meta-analysis of ACM. There
is some evidence that compliant patients have higher ACM
rates in the 5 years after EVAR (year 1, OR 5.77 [95% CI
0.74e45.14]; year 3, OR 2.28 [95% CI 0.92e5.66]; year 5,
OR 1.81 [95% CI 0.88e3.74]); however, this did not reach
statistical signiﬁcance (Table 3, Fig. 3). Overall quality of
evidence is “moderate” (Table 2).12
ACM and laxity index. Meta-regressions generally suggest
that larger laxity indices are associated with larger ORs for
overall survival (Tables 4 and 5, Figs. S11eS15). This
observation strengthens the conclusions that ACM may be
higher in more compliant patient groups, although no
regression was statistically signiﬁcant.
Re-intervention after EVAR. In total, 8316 (4298 compliant
and 4018 non-compliant) patients contributed to meta-
analysis of re-intervention after EVAR. There was no
statistically signiﬁcant difference in the intervention rate
between the two groups for the ﬁrst 2 years after EVAR
(year 1, OR 6.36 [95% CI 0.23e172.73]; year 2, OR 8.08
[95% CI 0.25e262.57]). However, re-intervention rates were
statistically signiﬁcantly higher in compliant patients for
years 3e5 after EVAR (year 3, OR 3.94 [95% CI 1.46e10.69];
year 4, OR 4.37 [95% CI 1.31e14.57]; year 5, OR 5.34 [95%
CI 1.87e15.29]) (Table 6, Fig. 4). Overall quality of evidence
is “low” (Table 2).12
Secondary outcome
AAA related mortality. In total, 12,995 patients (5890
compliant and 7105 non-compliant) contributed to this
analysis. Although there is some evidence that the rate of
ARM is higher in compliant patients, this was not statisti-
cally signiﬁcant (OR 1.47, 95% CI 0.99e2.19; p ¼ .06)
(Tables 7 and 8). Overall quality of evidence is “very low”
(Table 2).12
Sensitivity analysis (excluding Hicks et al.16)
ACM. In total, 13,407 patients (6182 compliant and 7225
non-compliant) contributed. The ACM rate was statistically
signiﬁcantly higher in compliant patients compared with
non-compliant patients in the 5 years after EVAR (year 1,
OR 9.85 [95% CI 1.14e84.98]; year 2, OR 5.10 [95% CI
1.57e16.56]; year 3, OR 3.26 [95% CI 1.50e7.06]; year 4,
OR 2.68 [95% CI 1.35e5.33]; year 5, OR 2.09 [95% CI 1.00e
4.35]; see Table S3). These results were sensitive to the
decision of whether or not to include this study.
DISCUSSION
This study highlights the wide variation in published rates of
compliance with surveillance after EVAR and conﬁrms thecompliance to Endovascular Aneurysm Repair Surveillance: A Systematic
rgery (2017), https://doi.org/10.1016/j.ejvs.2017.11.030
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Full- text arcles assessed for 
eligibility 
(n = 31) Records excluded 
(n = 18)
1. Analysis of one stent- gra23
2. Inability to exclude thoracic pathology9
3. No subgroup analysis by compliance to 
surveillance22,24,25
4. Inability to determine period of non-
compliance26
5. Inability to deﬁne the non-compliant group 
adequately27
6. Descripve analysis of rupture aer EVAR28
7. Discussion of outcomes of two types of stent-
gra29
8. Same cohort populaon was used for analysis 
on compliance in another cited study10
9. No Kaplan–Meier graphs or at- risk scores
available for compliant and non-compliant 
groups30–36
10. Systemac review only37
Records excluded 
(n = 6)
1. Diﬀerent deﬁnion of compliance 
(informaon obtained from author)38
2. No Kaplan–Meier curve/similar data for 
compliant and non-compliant data for outcomes 
chosen8,15,17,38,39,43
Figure 1. Preferred Items for Reporting of Systematic Reviews and Meta-Analyses (PRISMA) ﬂowchart.
Note. EVAR ¼ endovascular aneurysm repair.
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Figure 2. Meta-analysis of proportions of non-compliance. Meta-analysis of proportions of non-compliance to endovascular aneurysm
repair surveillance using data from the seven studies eligible for comparative meta-analysis, termed “main studies”, was carried out. An
overall meta-analysis of proportions of non-compliance using the data from all the studies in the systematic review (even if not eligible for
comparative meta-analysis) was carried out. The overall result is shown next to the “model for all studies”.
EVAR Surveillance: A Systematic Review and Meta-analysis 5previously published reports of lack of adherence to sur-
veillance programmes.8,19 Despite the recommendation by
international guidelines that EVAR surveillance is manda-
tory, it was found in the present review that only around
60% of patients are compliant with their surveillance
programmes.
The safety implications of non-compliance have previ-
ously been ill deﬁned. Although there was no statistically
signiﬁcant difference, the present results suggest that
compliant patients may have higher ACM rates than non-
compliant patients. However, the current analyses do not
imply any causal link between surveillance and survival,
and, as a result, the authors recommend that this ﬁnding be
interpreted with caution and not be taken at face value.
Potential reasons for this result are likely to be multi-
factorial. This may be because sicker patients have more
imaging for unrelated problems and therefore show a
higher rate of overall mortality in the compliant group. This
phenomenon was highlighted in a multicentre European
study and a US population based study.19,41 However, in the
study by Schanzer et al.,8 Medicare patients with comor-
bidities and cardiovascular risk factors were more non-
compliant. The authors hypothesised that patients with
competing medical pathologies become less inclined to
attend EVAR surveillance. Subsequently, given the obser-
vation of different attitudes by patients with a high co-
morbid status, it may indicate that surveillance programmes
need to be tailored according to the catchment population.
The mode of presentation to imaging surveillance could
potentially explain the results of this meta-analysis. ThePlease cite this article in press as: Grima MJ, et al., The Implications of Non-
Review and Meta-analysis, European Journal of Vascular and Endovascular Sustudy by Karthikesalingam et al. showed that around 60% of
patients who had re-intervention presented with symp-
toms,4 whereas the systematic review by Nordon et al.
showed that >90% of patients presented with symptoms.3
Thus, patients who were asymptomatic and potentially
healthier were less likely to attend surveillance. This may
explain the trend of better survival rates in non-compliant
patients and why complications were noted to be higher
in compliant groups.21,41 Kret et al. analysed a mixed cohort
of treated aortic pathologies and observed that complica-
tions were higher in the compliant group,9 which is in line
with the results of this review.
The present study showed that the re-intervention rate
was statistically signiﬁcantly higher in compliant patients for
years 3e5 after EVAR. In contrast to this outcome, despite
no difference in re-interventions or endoleak, Jones et al.
noted a signiﬁcantly higher rate of major complications in
non-compliant patients. Major complication was deﬁned as
any complication requiring urgent surgery; however, no
deﬁnition was provided for re-intervention. This contrasts
with the study by Garg et al.,19 whereby the statistical dif-
ference between the two groups persisted, even when all
complications, including late rupture or re-intervention,
were analysed together. The results of this meta-analysis
do not come as a surprise, as the aim of surveillance is to
identify asymptomatic complications to allow re-
intervention in order to prevent ARM.
The present study indicates that while compliant patients
had higher rates of re-intervention, compliance with sur-
veillance was not associated with a lower ARM. This raises acompliance to Endovascular Aneurysm Repair Surveillance: A Systematic
rgery (2017), https://doi.org/10.1016/j.ejvs.2017.11.030
Table 2. Overall GRADE quality assessment for each outcome.12
Studies (n) Study design Risk of bias Inconsistency Indirectness Imprecision Publication bias Quality
Overall compliance
13 Observational studies Not serious Serious Not serious Not serious Undetected/not tested 444
MODERATE
ACM
7 Observational studies Not serious Not serious Serious Not serious Undetected/not tested 444
MODERATE
Re-interventions
3 Observational studies Not serious Not serious Serious Serious Undetected/not tested 444
LOW
Aneurysm related mortality
4 Observational studies Serious Not serious Serious Not serious Undetected/not tested 4
VERY LOW
Note. GRADE ¼ Grading of Recommendations, Assessment, Development and Evaluations; ACM ¼ all cause mortality.
Table 1. Meta-analysis of proportions, along with deﬁnitions of, non-compliance and the overall compliant and non-compliant numbers in
each study.
Study Deﬁnition of non-compliance Total
number of
patients
Non-compliant
patients (n)
Compliant
patients (n)
Main study
Schanzer et al.8 Deﬁned as “prolonged time period”: a patient
who did not undergo at least one imaging study
during each 2 y interval that they were alive after
EVAR
7666 3879 3787 No
Godfrey et al.38 No imaging within the preceding 12 months (2
months) of the surveillance visits
179 50 129 No
Dias et al.15 Non-attendance at yearly CT scans 279 5 274 No
Aburahma et al.39 No follow-up imaging (CT and/or DUS) for 2 y at
any time during follow-up and/or missed ﬁrst
post-EVAR imaging over 6 mo
565 323 242 No
Cohen et al.43 Not compliant to follow-up protocol: 30 d, 1 y,
and annual follow-up
517 92 425 No
De Mestral et al.17 Deﬁned as “minimum appropriate imaging
follow-up”: CT scan or an ultrasound of the
abdomen within 90 d of EVAR and every 15 mo
thereafter
4902 2043 2859 No
Garg et al.19 Deﬁned as “incomplete surveillance” if
surveillance gaps between images was longer
than 15 mo
9695 5526 4169 Yes
Jones et al.40 Any patient who missed  2 consecutive follow-
up ofﬁce visits
302 99 203 Yes
Leurs et al.41 Patients missing  1 follow-up appointments 4433 2895 1538 Yes
Sarangarm et al.42 Any patient who missed > 2 consecutive follow-
up ofﬁce visits
126 19 107 Yes
Waduud et al.20 Patients who underwent no imaging in the ﬁrst
12 mo after EVAR or who missed any subsequent
annual imaging appointments thereafter
569 268 301 Yes
Wu et al.21 Deﬁned as “moderately compliant” if patients
missed appointments or surveillance imaging
(either one appointment or multiple ones) but
continued to follow-up thereafter
188 99 89 Yes
Hicks et al.16 Follow-up is an independent variable in the VQI
registry. Patients are recorded as having only a
single follow-up. If a patient had multiple follow-
up visits, the latest recorded follow up status was
used. (Assumption: in person follow up as
compliant and telephone call follow-up as non-
compliant.)
11,309 2461 8848 Yes
Note. EVAR ¼ endovascular aneurysm repair; CT ¼ computed tomography; DUS ¼ duplex ultrasound; VQI ¼ vascular quality initiative.
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Table 3. Comparative meta-analyses of all cause mortality.
Time point (y) OR 95% CI lower 95% CI upper p-value I2 s2 Q p value (Q)
1 5.77 0.74 45.14 0.10 92.95 6.48 36.71 <0.01
2 3.20 0.86 11.96 0.08 97.16 2.75 279.09 <0.01
3 2.28 0.92 5.66 0.08 95.87 1.27 218.82 <0.01
4 1.99 0.89 4.45 0.10 94.43 0.95 133.21 <0.01
5 1.81 0.88 3.74 0.11 90.60 0.71 89.77 <0.01
Note. Odds ratio (OR) > 1 indicates that the mortality rate is higher in compliant patients.
Figure 3. Summary of estimated average all cause mortality rates
from ﬁve meta-analyses. (odds ratio [OR] > 1 indicates that the
average mortality rate is higher in compliant patients). Forest plots
for each of the ﬁve meta-analyses that contribute to this ﬁgure are
shown in the Supplementary Material.
EVAR Surveillance: A Systematic Review and Meta-analysis 7number of issues, one being whether the increased re-
intervention rate in compliant patients is reﬂected in the
observed trend of increased overall mortality and ARM in
compliant patients. As a result, more questions arise as toTable 4. Laxity index criteria and explanation.
Study Laxity index Surveillance proto
Leurs et al.41 0 Surveillance 1, 3,
24 mo, then annu
Wu et al.21 0.125 Surveillance 1 and
then annually (but
surgeon or case)
Jones et al.40 0.25 Surveillance: 1 wk
6 mo for 2 y, then
Sarangarm et al.42 0.5 Surveillance: 1 mo
for 2 y, then annu
Garg et al.19 0.63 Surveillance: 1 mo
abnormal 1 mo sc
then annually
Hicks et al.16 1 Last recorded visit
up. SVS guidelines
annually after EVA
Waduud et al.20 1 Surveillance varies
Note. Non-compliance in terms of months without scan (every
EVAR ¼ endovascular aneurysm repair.
Please cite this article in press as: Grima MJ, et al., The Implications of Non-
Review and Meta-analysis, European Journal of Vascular and Endovascular Suwhether EVAR surveillance is potentially causing unnec-
essary treatment with the possibility of iatrogenic harm.
Another issue is whether the aim of EVAR surveillanced-
that of detecting and treating asymptomatic sac size in-
crease before causing ARMdis being reached. However, the
authors acknowledge that this paper did not study the
causality between these outcomes.
This meta-analysis indicates that re-intervention rates for
both groups during the ﬁrst 2 years after EVAR, is very low.
Similarly, death events at 1 year after EVAR are low. Hicks
et al. also showed that non-compliance with surveillance
during the ﬁrst year after EVAR had a detrimental effect on
survival and explains why inferences are sensitive to the
inclusion or exclusion of this study.16
Apart from this observation, as there is no statistically
signiﬁcant difference in mortality between the two groups
during the ﬁrst 5 years after EVAR, and given that some
published studies show that few asymptomatic complica-
tions are detected at surveillance,4,9 this study potentially
highlights the beneﬁt of risk stratiﬁcation of EVAR surveil-
lance after the ﬁrst year of surveillance. Although it is not
the remit of this study to discuss ways of stratiﬁcation, a
model developed by this institution (St George’s Vascular
Institute score44) stratiﬁed patients into high and low risk
for developing complications using their pre-operative
aortic sac size and iliac diameter. Bastos Gonçalves et al.
showed that patients with early sac shrinkage, adequatecol Deﬁnition of non-compliance
6, 12, 18, and
ally
Incomplete ¼ missing 1
12 months
can vary by
Moderate compliance ¼ missed  1
, 1 mo, every
annually
Incomplete¼ missed  2
follow-up appointments
, every 6 mo
ally
Incomplete¼missed > 2
consecutive appointments
(6 mo if
an), 12 mo,
Incomplete ¼ gaps of 15
mo without surveillance
in 1 y follow-
: 30 d, 1 y, and
R
Did not attend any in person
follow-up after EVAR
Incomplete ¼ no imaging in the
ﬁrst 12 mo or missed any
subsequent annual imaging surveillance
0.5 ¼ 12 month gap). SVS ¼ Society for Vascular Surgery;
compliance to Endovascular Aneurysm Repair Surveillance: A Systematic
rgery (2017), https://doi.org/10.1016/j.ejvs.2017.11.030
Table 5. Meta-regression analysis of all cause mortality using the
laxity index.
Time point (y) Coefﬁcient 95% CI lower 95% CI upper p value
1 1.63 4.27 7.54 0.59
2 0.61 3.17 4.39 0.75
3 0.09 2.72 2.55 0.95
4 0.23 2.09 2.56 0.84
5 0.98 0.88 2.84 0.30
Note. A positive regression coefﬁcient indicates that larger laxity
values are associated with larger odds ratios. CI ¼ conﬁdence
interval.
8 Matthew Joe Grima et al.EVAR seal and no endoleak during the ﬁrst year after EVAR
have low risk of late complications.45,46 As a result, re-
sources could be directed to improving and encouraging
compliance in high risk patients while subjecting asymp-
tomatic and low risk patients to lower risks of radiation
exposure and nephrotoxic effects without the increased risk
of re-intervention and mortality.47,48Figure 4. Summary of all estimated average re-intervention rates
from ﬁve meta-analyses. (odds ratio [OR] > 1 indicates that the
average re-intervention rate is higher in compliant patients). For-
est plots for each of the ﬁve meta-analyses that contribute to this
ﬁgure are shown in the Supplementary Material.Limitations
Different studies had different deﬁnitions for non-
compliance, whereas some studies grouped non-compliant
and lost to follow-up patients together.40 An attempt to
reduce this limitation effect was carried out through the
introduction of the laxity index for non-compliance.
Although meta-regression analyses perform better if the
number of studies analysed is  10,49 meta-regression
analysis was carried out to further assess whether compli-
ance is associated with ACM. The meta-regressions using
the laxity index, despite their limitations, generally support
the ﬁndings of the meta-analysis.
Another limitation is the way compliance data were
collected by different authors. The studies by Schanzer et al.
and Garg et al.,8,19 which had the largest cohort of patients,
included any imaging modality which captured EVAR. Thus,
one may question whether the imaging of some patients
was actually surveillance imaging. This may infer that overall
non-compliance with surveillance may actually be higher
than 42%.
Four studies analysed ARM. This event was rare and only
a small number of studies provided data, so methods for
meta-analysis cannot be expected to be very accurate in
this situation.
Another limitation is that deﬁnitions used for complica-
tions and re-intervention varied between studies. From the
three studies that provided KaplaneMeier curves for anal-
ysis of re-intervention, two used the term re-interventionTable 6. Comparative meta-analyses of re-intervention.
Time point (y) OR 95% CI lower 95% CI upper
1 6.36 0.23 172.73
2 8.08 0.25 262.57
3 3.94 1.46 10.69
4 4.37 1.31 14.57
5 5.34 1.87 15.29
Note. Odds ratio (OR) > 1 indicates that the average intervention rate
Please cite this article in press as: Grima MJ, et al., The Implications of Non-
Review and Meta-analysis, European Journal of Vascular and Endovascular Sufor AAA complications,19,42 whereas the study by Jones
et al. tried to differentiate between the two terms.40
Despite difﬁculty with this deﬁnition, the authors feel that
this should not bias the result of the meta-analysis as the
study by Garg et al. had a very large patient cohort
compared with the study by Jones et al.27,30 This was
further conﬁrmed by the EUROSTAR registry,41 which
showed signiﬁcantly fewer endoleaks, graft migrations, and
transfemoral secondary interventions in non-compliant
patients.
A further limitation is the lack of adjustment for signiﬁ-
cant confounders across all outcomes. Elective and emer-
gency cases of AAA repair could not be distinguished to
statistically assess the impact on survival and re-
intervention rate. However, this may not have biased the
results as the population based study by Schanzer et al. and
the Medicare population study by Garg et al. showed that
patients who had emergency rupture were more likely to be
non-compliant.8,10 Although the authors are unaware of
whether emergency AAA repairs were included in two
studies,20,40 the study by Leurs et al. and Hicks et al., with
large cohorts of patients, had only elective cases,16,41
whereas the compliant and non-compliant groups in the
study by Wu et al. had equal proportions of emergency AAAp-value I2 s2 Q p value (Q)
0.27 88.23 7.38 13.75 <0.01
0.24 91.66 8.48 14.61 <0.01
0.01 67.96 0.51 7.00 0.03
0.02 74.22 0.80 9.25 0.01
<0.01 57.80 0.50 4.84 0.09
is higher in the compliant patients. CI ¼ conﬁdence interval.
compliance to Endovascular Aneurysm Repair Surveillance: A Systematic
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Table 7. Aneurysm related mortality (ARM), overall data, and deﬁnitions of ARM.
Study Compliant patients Non-compliant patients Deﬁnition Length of
follow-up (y)Total number
of patients (n)
Mortality (n) Total number of
patients (n)
Mortality (n)
Garg et al.19 3944 24 3944 13 “Aneurysm related in hospital
mortality”
10
Sarangarm et al.42 107 3 19 0 “[D]ied from post-EVAR open
conversion complications”
7
Leurs et al.41 1538 21 2895 26 “[D]eaths due to aneurysm
rupture, a primary or secondary
procedure, or surgical
conversion”
7
Waduud et al.20 301 8 247 8 “AAA related death” 5
Note. EVAR ¼ endovascular aneurysm repair; AAA ¼ abdominal aortic aneurysm.
Table 8. Random effects meta-analysis of aneurysm related
mortality.
Overall OR 95% CI
lower
95% CI
upper
p-value I2 s2 Q p-value (Q)
1.47 0.99 2.19 0.06 0.00 0 1.82 0.61
Note. Odds ratio (OR) > 1 indicates that mortality rate is higher in
the compliant patients. CI ¼ conﬁdence interval.
EVAR Surveillance: A Systematic Review and Meta-analysis 9repairs.21 Furthermore, Garg et al. and Sarangarm et al.
excluded patients who had died within 30 days and those
who died within the ﬁrst year, respectively.19,42 Thus, the
trend effect of improved survival in the non-compliant
group because of fewer emergency AAAs is potentially
negligible. Further to the inability to adjust for emergency
procedures, it was not possible to adjust the results for
other signiﬁcant confounders across the outcomes. None of
the studies, except the studies by Garg et al. and Hicks
et al.,16,19 provided analysis after propensity matching.CONCLUSION
This study suggests that although surveillance is associated
with an increased rate of re-interventions, it does not
appear to be associated with improved survival. Thus,
improved evidence based surveillance programmes are ur-
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